MTS Atlas
Built with+
SituationsJobsCompaniesModelsInvestorsProfile
← All investors
RVRadical Ventures logo

Firm & fund profile / Sourced portfolio

Radical Ventures

Tracked participation in 15 Atlas companies, with 11 explicitly attributed leads.

Firm website ↗
15portfolio companies
28round participations
11lead positions
$1.9Bled round total
Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Jul 2026Prime IntellectSeries A$130Mat $1B valuationJun 2026Generalist AISeries B (new funding announcement; company blog)$400Mat $2B valuationMay 2026DecartSeries C (reported as a $300M funding round)$300Mat $4B valuationAug 2025CohereUnspecified round (reported as a $500M round)$500Mat $6.8B valuationFeb 2025Latent LabsSeries A$40MFeb 2025Latent LabsSeries A (co-led)$40M
Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleLatest round
GAGeneralist AI logoGeneralist AI$3BJun 2026 → Aug 20262 rounds1 ledSeries B extension (reported)
PIPrime Intellect logoPrime Intellect$1BJul 2026 → Jul 20261 round1 ledSeries A
TLTwelve Labs logoTwelve Labs—Mar 2022 → Jul 20264 rounds1 ledSeries B
EEtched logoEtched—Jun 2026 → Jun 20261 roundParticipantStealth exit announcement (cumulative funding disclosed)
OMOrbital Materials logoOrbital Materials—Feb 2024 → May 20262 rounds1 ledSeries B
DDecart logoDecart$4BMay 2026 → May 20261 round1 ledSeries C (reported as a $300M funding round)
WWaabi logoWaabi—Jun 2021 → Jan 20263 roundsParticipantSeries C
CCrusoe logoCrusoe$10BOct 2025 → Oct 20251 roundParticipantSeries E
CCohere logoCohere$7BSep 2021 → Sep 20254 rounds1 ledSecond close (latest round extension)
LLLatent Labs logoLatent Labs—Feb 2025 → Feb 20252 rounds2 ledSeries A
WWriter logoWriter$1.9BNov 2024 → Nov 20241 round1 ledSeries C
WLWorld Labs logoWorld Labs$1BApr 2024 → Sep 20243 rounds1 ledSeries A (or unicorn-status priced equity round; reported as $230M across two rounds)
NBNabla Bio logoNabla Bio—May 2024 → May 20241 round1 ledSeries A
HHebbia logoHebbia—Sep 2022 → Sep 20221 roundParticipantSeries A
GTGenesis Therapeutics logoGenesis Therapeutics—Dec 2020 → Dec 20201 roundParticipantSeries A